Skip to content

Efficacy of a Bilberry-based Probiotic Product on Glucose Tolerance and Insulin Resistance

The Long Term Efficacy of a Bilberry-based Probiotic Product on Glucose Tolerance and Insulin Resistance as Compared to a Control.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03185676
Enrollment
32
Registered
2017-06-14
Start date
2017-05-02
Completion date
2017-11-30
Last updated
2018-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance

Brief summary

The impact of a bilberry-based probiotic drink on the postprandial levels of serum glucose and insulin have already been study in the past. The aim of the current study is to evaluate the long term effect of the probiotic bilberry drink on glucose tolerance and insulin resistance in healthy adults and in comparison to a control drink.

Interventions

A bilberry based probiotic beverage

OTHERbeverage without bilberries or probiotics

A control beverage without bilberries or probiotics

Sponsors

Lund University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Healthy adults with a BMI between 20-30

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
The long term effect of a bilberry-based probiotic beverage on postprandial levels of serum insulinIncremental area under the curve for serum insulin from 0 min up to 120 min following the ingestion of the study productThe incremental area under the curve (AUC) will be measured for the levels of postprandial serum insuling from 0 min to 120 min following ingestion of the product (included intermediate measuring time points are 30, 60 and 90 min)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026